Discover more insights into Pd L1 Blockade Pd L1 봉쇄

Keywords frequently search together with Pd L1 Blockade Pd L1 봉쇄

Narrow sentence examples with built-in keyword filters

Pd L1 Blockade sentence examples within programmed death ligand



Sanguisorbae Radix Suppresses Colorectal Tumor Growth Through PD-1/PD-L1 Blockade and Synergistic Effect With Pembrolizumab in a Humanized PD-L1-Expressing Colorectal Cancer Mouse Model


PD0325901, an ERK inhibitor, enhances the efficacy of PD-1 inhibitor in non-small cell lung carcinoma


Wnt Inhibition Sensitizes PD-L1 Blockade Therapy by Overcoming Bone Marrow-Derived Myofibroblasts-Mediated Immune Resistance in Tumors



PD-L1P146R is prognostic and a negative predictor of response to immunotherapy in gastric cancer.


More Pd L1 Blockade Pd L1 봉쇄 sentence examples
10.1200/JCO.2021.39.15_SUPPL.E15056

Bispecific anti-PD-1/PD-L1 antibody CTX-8371 to promote cellular clustering and PD-1 shedding, antitumor activity and tolerability.



PD-1/PD-L1 Blockade: Prospectives for immunotherapy in Cancer and Autoimmunity.



A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells



Programmed death-ligand 1 expression in swine chronic infections and enhancement of interleukin-2 production via programmed death-1/programmed death-ligand 1 blockade.



OTHR-02. Engineered “of the shelf” allogeneic cellular therapies for metastatic brain tumors



Overcome the tumor immunotherapy resistance by combination of the HDAC6 inhibitors with antitumor immunomodulatory agents.



Expression Patterns of Immune Checkpoints in Breast Cancer Patients



Nivolumab Induced Multiple Endocrinopathies; Adrenal Insufficiency and Primary Hypothyroidism in a Patient With Stage IV Gastric Cancer - A Case Report



Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies



Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers



Assessment of PD-L1 Expression on Circulating Tumor Cells for Predicting Clinical Outcomes in Cancer Patients Receiving PD-1/PD-L1 Blockade Therapies.


More Pd L1 Blockade Pd L1 봉쇄 sentence examples
10.3779/j.issn.1009-3419.2021.102.23

[Cardiotoxicity of Anti-PD-L1 Antibody and the Effect of Levothyroxine 
in Attenuating the Related Mortality in Mice].



Tumor-targeted gene therapy with lipid nanoparticles inhibits tumor-associated adipocytes and remodels the immunosuppressive tumor microenvironment in triple-negative breast cancer.



Flow cytometry detection of cell type-specific expression of programmed death receptor ligand-1 (PD-L1) in colorectal cancer specimens



Carnosic acid-induced co-self-assembly of metal-peptide complexes into a nanocluster-based framework with tumor-specific accumulation for augmented immunotherapy



Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes



Soluble Programmed Death-Ligand 1 (sPD-L1) as a Novel Biomarker for the Combination of Anti-PD-L1 Antibody and Radiotherapy for Glioma Patients.



Determining PD-L1 expression in head and neck squamous cell carcinoma using immunohistochemistry.



Abstract LB197: An SU2C-Mark Foundation Lung collaborative update: integrative genomics identifies distinct transcriptional states associated with checkpoint blockade resistance



Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer



Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosis



Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer


More Pd L1 Blockade Pd L1 봉쇄 sentence examples
10.1200/JCO.2021.39.15_SUPPL.11551

Durvalumab and pazopanib in patients with advanced soft tissue sarcoma: A single-center, single-arm, phase 2 trial.



Laminin γ2–mediating T cell exclusion attenuates response to anti–PD-1 therapy



Identification of an Individualized Metabolism Prognostic Signature and Related Therapy Regimens in Early Stage Lung Adenocarcinoma



Anti-PD-1/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies



Intracellular aggregation of peptide-reprogrammed small molecule nanoassemblies enhances cancer chemotherapy and combinatorial immunotherapy



Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer



Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity.



Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer


More Pd L1 Blockade Pd L1 봉쇄 sentence examples
10.1182/bloodadvances.2021004511

Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial.



Immunogenomic Gene Signature of Cell-Death Associated Genes with Prognostic Implications in Lung Cancer


More Pd L1 Blockade Pd L1 봉쇄 sentence examples
10.2174/1871530321666210310142141

The Potential of T Cell Immunoglobulin and Mucin-Domain containing-3 (Tim-3) in Designing Novel Immunotherapy for Bladder Cancer.



Mechanisms of primary and acquired resistance to PD-1/PD-L1 blockade and the emerging role of gut microbiome


More Pd L1 Blockade Pd L1 봉쇄 sentence examples
10.1158/1557-3265.ENDOMET20-IA010

Abstract IA010: Immunology of endometrial cancers: Tumor genetics, immune recognition, and immunotherapy response



Single-cell transcriptomics reveals the effect of PD-L1/TGF-β blockade on the tumor microenvironment



CCL21 synergized with PD-L1 blockade restrains tumor growth.


More Pd L1 Blockade Pd L1 봉쇄 sentence examples
10.1016/j.biomaterials.2021.120685

Anticancer nanocage platforms for combined immunotherapy designed to harness immune checkpoints and deliver anticancer drugs.



The Mechanisms Leading to Distinct Responses to PD-1/PD-L1 Blockades in Colorectal Cancers With Different MSI Statuses



Adipose-Tissue-Derived Mesenchymal Stem Cells Mediate PD-L1 Overexpression in the White Adipose Tissue of Obese Individuals, Resulting in T Cell Dysfunction



Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function



Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer



Resistance Mechanisms to Programmed Cell Death Protein 1 and Programmed Death Ligand 1 inhibitors.



Photodynamic Therapy Synergize with PD-L1 Checkpoint Blockade for Immunotherapy of Colorectal Cancer by Multifunctional Nanoparticle.



Intra-tumoral CD39+CD8+ T cells predict response to PD-1/PD-L1 blockade in patients with NSCLC.



Abstract 1657: Tumor selective immunotherapy to overcome checkpoint blockade resistance


More Pd L1 Blockade Pd L1 봉쇄 sentence examples
10.1016/j.critrevonc.2021.103223

Immunotherapy addition to neoadjuvant chemotherapy for early triple negative breast cancer: a systematic review and meta-analysis of randomized clinical trials.



A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer


Learn more from Pd L1 Blockade Pd L1 봉쇄

Pd L1 Blockade Pd L1 봉쇄


Pd L1 Blockade Pd L1 봉쇄
Encyclopedia 백과사전